Landos Biopharma Company
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
.png)
Last Funding Type:
Series B
Funding Status:
IPO
Headquarters:
Blacksburg, Virginia, United States
Founded Date:
2017-06-01
Last Funding Date:
2019-08-13
Total Funding:
70000000.0
Estimated Revenue:
$1M to $10M
Investors Number:
6.0
Industry:
End-to-End Drug Development